Quarterly report [Sections 13 or 15(d)]

Segment Information

v3.26.1
Segment Information
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
We view our operations and manage our business as one operating segment, and our chief operating decision maker (CODM) is our chief executive officer. The following table presents segment information for the periods presented (in thousands):
Three Months Ended March 31,
2026 2025
Total Revenues $ 58,818  $ 53,333 
Less:
Employee related expenses 21,002  19,538 
Commercial related expenses 7,040  5,339 
Outside clinical trial related expenses 6,927  4,371 
Cost of product sales 4,606  4,409 
Consultants and third-party services 4,006  3,409 
Other segment items 3,352  3,494 
Interest expense, net 228  1,262 
Provision for income taxes 3,003  65 
Segment income $ 8,654  $ 11,446 
There are no reconciling items or adjustments between segment income presented above and net income as presented in our statements of operations. The CODM does not review assets in evaluating the segment performance, accordingly, such information is not presented.
For details of revenues disaggregated by category, see “Note 3 – Revenues.”
Employee related expenses primarily consist of salaries, employee benefits, other employee related expenses and stock-based compensation expense. For additional details of stock-based compensation expense, see “Note 6 – Stock-Based Compensation.” Other segment items for the periods presented primarily consist of travel related expenses, business insurance, taxes and licenses, and subscription services.